Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer
Objective To evaluate the prognostic significance of hematological toxicities during cervical cancer treatment. Methods Patients treated for cervical carcinoma with definitive chemoradiation were identified. Toxicities were assessed during weeks 1 to 6 of concurrent external beam radiation and chemo...
Saved in:
Main Authors: | Feiya Shi (Author), Alison K. Yoder (Author), Claire Mach (Author), Shraddha Dalwadi (Author), Matthew L Anderson (Author), Tracilyn R Hall (Author), Michelle S Ludwig (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Obstetrics and Gynecology,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concurrent chemoradiation versus radiotherapy alone for the treatment of locally advanced cervical cancer in a low-resource setting
by: Elena Pereira, et al.
Published: (2017) -
A Case of Recurrent Esophageal Cancer Treated with Concurrent Chemoradiation Therapy in Pregnancy
by: Kaori Yamada, et al.
Published: (2018) -
Effect of GSDMB polymorphism on sensitivity to chemoradiation therapy for cervical cancer
by: Ni Zhong, et al.
Published: (2021) -
Treatment Response of PlatinumBased Chemoradiation on Locally Advanced Cervical Cancer
by: Oni Khonsa, et al.
Published: (2015) -
Factors predictive of parametrial boost in patients with cervical cancer treated with definitive chemoradiation
by: Kurl E. Jamora, et al.
Published: (2022)